Modi; Rajiv Indravadan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Modi; Rajiv Indravadan.The latest application filed is for "synthesis of novel intermediate(s) for preparing rivastigmine".
- Modi; Rajiv Indravadan - Gujarat IN
- Modi; Rajiv Indravadan - Ahmedabad IN
- Modi; Rajiv Indravadan - US
| Patent | Date |
|---|---|
| Synthesis of novel intermediate(s) for preparing rivastigmine Grant 10,882,819 - Yadav , et al. January 5, 2 | 2021-01-05 |
| Synthesis Of Novel Intermediate(s) For Preparing Rivastigmine App 20200095195 - Yadav; Jhillu Singh ; et al. | 2020-03-26 |
| Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity App 20180042850 - Khamar; Bakulesh Mafatlal ; et al. | 2018-02-15 |
| Pharmaceutical composition of killed cells with substantially retained immunogenicity Grant 9,795,659 - Khamar , et al. October 24, 2 | 2017-10-24 |
| Stable pharmaceutical composition for atherosclerosis Grant 9,789,187 - Khamar , et al. October 17, 2 | 2017-10-17 |
| Cancer antigen Grant 9,714,275 - Modi , et al. July 25, 2 | 2017-07-25 |
| Indole 3-carbinol derivatives Grant 9,708,258 - Modi , et al. July 18, 2 | 2017-07-18 |
| Pharmaceutical compositions of curcumin Grant 9,474,727 - Khamar , et al. October 25, 2 | 2016-10-25 |
| Hypoglycemic compounds Grant 9,029,567 - Khamar , et al. May 12, 2 | 2015-05-12 |
| Novel Dipeptidyl Peptidase Iv (dp-iv) Compounds App 20140045771 - Khamar; Bakulesh Mafatlal ; et al. | 2014-02-13 |
| Farnesoid-X-receptor antagonist as a vaccine adjuvant Grant 8,647,643 - Khamar , et al. February 11, 2 | 2014-02-11 |
| Dipeptidyl peptidase IV (DP-IV) compounds Grant 8,563,517 - Khamar , et al. October 22, 2 | 2013-10-22 |
| Pharmaceutical Compositions Of Curcumin App 20130225689 - Khamar; Bakulesh Mafatlal ; et al. | 2013-08-29 |
| Novel Hypoglycemic Compounds App 20130150578 - Khamar; Bakulesh Mafatlal ; et al. | 2013-06-13 |
| Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity App 20120308605 - Khamar; Bakulesh Mafatlal ; et al. | 2012-12-06 |
| Vaccine adjuvants Grant 8,277,778 - Khamar , et al. October 2, 2 | 2012-10-02 |
| Process for manufacturing pharmaceutical composition comprises of Mycobacterium w in the treatment of asthma (obstructive lung disease) Grant 8,153,102 - Modi , et al. April 10, 2 | 2012-04-10 |
| Stable Pharmaceutical Composition For Atherosclerosis App 20120027849 - Khamar; Bakulesh Mafatlal ; et al. | 2012-02-02 |
| Vaccine Adjuvants App 20120014985 - KHAMAR; BAKULESH MAFATLAL ; et al. | 2012-01-19 |
| Vaccine adjuvants Grant 8,048,434 - Khamar , et al. November 1, 2 | 2011-11-01 |
| Novel Dipeptidyl Peptidase Iv (dp-iv) Compounds App 20110183919 - Khamar; Bakulesh Mafatlal ; et al. | 2011-07-28 |
| Mitogen Activated Protein Kinase Modulator App 20100209394 - Modi; Rajiv Indravadan ; et al. | 2010-08-19 |
| Vaccine Adjuvants App 20080131458 - Khamar; Bakulesh Mafatlal ; et al. | 2008-06-05 |
| Stable oral pharmaceutical formulation containing an anti-infective agent and a microorganism App 20020025309 - Modi, Rajiv Indravadan ; et al. | 2002-02-28 |
| Preparation of an oral pharmaceutical formulation containing an anti-infective agent and a microorganism Grant 6,306,391 - Modi , et al. October 23, 2 | 2001-10-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 